Showing results (291-300 of 663) with videos related to

Sort By:
Pageof 67
Journal of Endourology|September 24, 2021
The Role of 3D Models Obtained from Multiparametric Prostate MRI in Performing Robotic ProstatectomyAlberto Martini, Ugo Giovanni Falagario, Shivaram Cumarasamy, et al.
Arthritis and Rheumatism|June 3, 2008
Hypoxic synovial environment and expression of macrophage inflammatory protein 3gamma/CCL20 in juvenile idiopathic arthritisMaria Carla Bosco, Silvana Delfino, Francesca Ferlito, et al.
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|September 17, 2019
Clinical implications of prostatic capsular abutment or bulging on multiparametric magnetic resonance imagingAlberto Martini, Shivaram Cumarasamy, Akriti Gupta, et al.
World Journal of Urology|June 18, 2024
Patient experience and satisfaction after same-day discharge radical prostatectomy using a personalized, digital perioperative programmeDaniele d'Agate, Alberto Martini, Marine Lesourd, et al.
Cancers|March 28, 2026
Nerve-Sparing in High-Risk Prostate Cancer: Advantages and Pitfalls of Current Strategies and TechnologiesDaniele Robesti, Pierluigi Russo, Giuseppe Fallara, et al.
Internal and Emergency Medicine|April 11, 2018
Management of idiopathic recurrent pericarditis in adults and in children: a role for IL-1 receptor antagonismAntonio Brucato, Giacomo Emmi, Luca Cantarini, et al.
The Journal of Rheumatology|April 15, 2026
Systematic literature review informing PReS/CARRA-endorsed recommendations for the treat-to-target strategy in juvenile dermatomyositisAna Isabel Rebollo-Giménez, Talia Baird, Brian M Feldman, et al.
RMD Open|December 10, 2016
Improving inflammatory arthritis management through tighter monitoring of patients and the use of innovative electronic toolsPiet van Riel, Rieke Alten, Bernard Combe, et al.
RMD Open|February 2, 2024
Defining criteria for disease activity states in juvenile dermatomyositis based on the Juvenile Dermatomyositis Activity IndexSilvia Rosina, Alessandro Consolaro, Angela Pistorio, et al.
Rheumatology (Oxford, England)|August 23, 2024
Long-term efficacy of MAS825, a bispecific anti-IL1β and IL-18 monoclonal antibody, in two patients with systemic JIA and recurrent episodes of macrophage activation syndromeRoberta Caorsi, Arinna Bertoni, Caterina Matucci-Cerinic, et al.
Pageof 67